C
18.14
0.16 (0.89%)
Market Trend
Short Term | Medium Term | ||
Industry | Biotechnology (US) | Mixed | Bearish |
Biotechnology (Global) | Mixed | Bearish | |
Stock | Cullinan Therapeutics, Inc. | Bullish | Bearish |
Stockmoo Score
-0.9
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. |
|
Sector | Healthcare |
Industry | Biotechnology |
Investment Style | Small Core |
52 Weeks Range | ||
Price Target Range | ||
High | 36.00 (Wedbush, 98.46%) | Buy |
Median | 32.00 (76.41%) | |
Low | 28.00 (HC Wainwright & Co., 54.36%) | Buy |
Average | 32.00 (76.41%) | |
Total | 2 Buy | |
Avg. Price @ Call | 17.95 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Wedbush | 18 Sep 2024 | 36.00 (98.46%) | Buy | 17.95 |
09 Aug 2024 | 36.00 (98.46%) | Buy | 16.77 | |
HC Wainwright & Co. | 17 Sep 2024 | 28.00 (54.36%) | Buy | 17.95 |
16 Sep 2024 | 28.00 (54.36%) | Buy | 17.95 |
Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
---|---|---|---|---|
MICHAELSON JENNIFER | - | 17.93 | -8,000 | -143,440 |
Aggregate Net Quantity | -8,000 | |||
Aggregate Net Value ($) | -143,440 | |||
Aggregate Avg. Buy ($) | - | |||
Aggregate Avg. Sell ($) | 17.93 |
Name | Holder | Date | Type | Quantity | Price | Value ($) |
---|---|---|---|---|---|---|
MICHAELSON JENNIFER | Officer | 05 Sep 2024 | Automatic sell (-) | 8,000 | 17.93 | 143,440 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |